Oupushifang Pharmaceutical Technology Co., Ltd.

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression	eye disorder, myopia, refractive error	Recruiting	Phase 3	2024-12-24		NCT06708156

Clinical trials